CD8A and neoplasm: To access whether increasing the intratumoral proportion and enhancing function of CD8+ T cells in IFI35-overexpressing tumor resulted in improving efficacy of immunotherapy, we established multiple models combining with IFI35 overexpression, seeking to uncover that IFI35 may enhance the efficacy of immunotherapy.